Double Billing: Regeneron MFN Deal Announced Along With Approval Of Its Gene Therapy

 
• By Cathy Kelly
  
Regeneron gets its turn in the Oval Office.
Regeneron gets its turn in the Oval Office (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip